Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: (KTRA) MC $34 M- Cash $23 M--2 Phase 3 Cancer Drugs

No earlier versions found for this Subject.

Return to (KTRA) MC $34 M- Cash $23 M--2 Phase 3 Cancer Drugs

(KTRA) Market Cap only 34 million/ Cash balance 23 million / 2 Cancer Drugs to start Phase 3 imminent -HUGE commercial opp of over $1+ Billion / LOTS of upcoming Major milestones (see Chart below) including Phase 2 readout of the Newly diagnosed GBM Study = MASSIVE Underpriced stock with significant upside potential could run to 10 dollar and more on positive readouts .GL

Company Presentation

d1io3yog0oux5.cloudfront.net

3 “Strong Buy” Healthcare Stocks Under $5 That Could Go Boom...

finance.yahoo.com